Vaccine News and Research

Latest Vaccine News and Research

Financial Times examines how Brazil's state-run drug sector is engaging in partnerships at home, abroad

"Dilma Rousseff had barely been confirmed as Brazil's new president in November when she made her first foreign visit, to Mozambique," which "included a symbolic stop-off at a pharmaceutical factory that is under construction in preparation for opening in 2014. … The plant will produce a range of medicines for one of its leading lusophone - Portuguese-speaking - African partners, marking the resurgent power and growing reach of its sponsor, Brazil's own state-led drug sector," the Financial Times writes in an article that examines the partnerships Brazil is establishing at home and abroad.

24 Dec 2010

Silencing of specific genes of germinal cell lines reduces brain tumors

Scientists at IRB Barcelona have discovered that some brain tumours in larvae of the fruit fly Drosophila melanogaster use the genetic programme of germline cells to grow. The removal of some of these genes leads to healthy brains. This finding demonstrates that these genes are crucial for tumour development. The study, headed by ICREA researcher Cayetano Gonz-lez, is published today in the prestigious journal Science.

24 Dec 2010

BROMG doctor calls for votes to win $25,000 Pepsi Refresh Grant to pay for more flu vaccine

Dr. M. George of the Birmingham Royal Oak Medical Group (BROMG) is well known for providing free flu shots for the past thirteen years to more than 28,000 people in his community at a cost of $300,000 to his clinic. He also provides free Doctor visits for the unemployed and the uninsured. Now, Doc George, as he is known, is asking for help to win a Pepsi Refresh Grant of $25,000 to pay for more flu vaccine.

23 Dec 2010

Scientist discovers molecular switch controlling synthesis of ribosomes

A scientist from the Florida campus of The Scripps Research Institute has discovered a molecular switch that controls the synthesis of ribosomes. Ribosomes are the large machineries inside all living cells that produce proteins, the basic working units of any cell. These new findings offer a novel target for potential treatments for a range of diseases, including cancer.

23 Dec 2010

Immunization with VLP vaccine results in functional, protective immune responses against RSV

Novavax, and scientists at the University of Massachusetts Medical School, led by Dr. Trudy Morrison, published in the January 2011 issue of The Journal of Virology, a report indicating that a novel virus-like particle vaccine candidate against respiratory syncytial virus (RSV) protects mice from a live virus challenge.

23 Dec 2010

Pfizer seeks FDA and EMA approval for expanded use of Prevnar 13 for pneumococcal disease

Pfizer Inc today announced that it has submitted supplemental applications to both the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA) to expand the use of Prevnar 13® (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) to adults 50 years of age and older for the prevention of pneumococcal disease caused by the 13 serotypes contained in the vaccine.

23 Dec 2010

Medicago completes first part of H5N1 vaccine Phase II trial

Medicago, a biotechnology company focused on developing highly effective and affordable vaccines based on proprietary manufacturing technologies and Virus-Like Particles, today announced that the last dose of vaccine has been administered completing the first part of the Company's Phase II human clinical trial with its H5N1 Avian Influenza vaccine.

23 Dec 2010

Merck announces FDA approval for GARDASIL against HPV-related anal cancer

Merck, known as MSD outside the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) has approved GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant] for the prevention of anal cancer caused by human papillomavirus (HPV) types 16 and 18 and for the prevention of anal intraepithelial neoplasia (AIN) grades 1, 2 and 3 (anal dysplasias and precancerous lesions) caused by HPV types 6, 11, 16 and 18, in males and females 9 through 26 years of age.

23 Dec 2010

Combination of antigen and wax nanoparticles improves immunogenicity

Particle Sciences, a leading pharmaceutical CRO has formulated a series of wax nanoparticles that, when coupled with an antigen, enhanced its immunogenicity, increasing both systemic and the mucosal immune response.

23 Dec 2010

FDA approves Gardasil for prevention of anal cancer

The U.S. Food and Drug Administration today approved the vaccine Gardasil for the prevention of anal cancer and associated precancerous lesions due to human papillomavirus (HPV) types 6, 11, 16, and 18 in people ages 9 through 26 years.

23 Dec 2010

New online tool helps scientists to find gene promoters

Researchers at The Wistar Institute announce the release of an online tool that will help scientists find "gene promoters"—regions along a DNA strand that tell a cell's transcription machinery where to start reading in order to create a particular protein.

22 Dec 2010

AIDS patients with serum biomarkers are predisposed to immune reconstitution inflammatory syndrome

A study in this week's PLoS Medicine suggests that AIDS patients with cryptococcal meningitis who start HIV therapy are predisposed to immune reconstitution inflammatory syndrome - an exaggerated inflammatory immune response that kills up to one-third of affected people - if they have biomarkers in their blood showing evidence of a damaged immune system that is not capable of clearing the fungal infection.

22 Dec 2010

CoreMatrix delivers new cloud based, integrated, on demand marketing solutions

CoreMatrix Systems™, one of the country's leading cloud computing consulting and Software-as-a-Service (SaaS) development companies, announced today that it has developed and delivered two new integrated, on demand marketing solutions. Built on Aprimo Marketing Studio® On Demand, the cloud-based solutions are designed to empower marketers to more efficiently execute and measure integrated marketing campaigns, while reducing costs, for improved ROI.

21 Dec 2010

Biovest issues FAQ update on BiovaxID personalized cancer vaccine

Biovest International, Inc. today issued the following update in the form of a "Frequently Asked Questions" report in response to the high volume of inquiries received following the Company's recent presentation at the 2010 American Society of Hematology Annual Meeting (ASH 2010) in Orlando, Florida.

21 Dec 2010

Researchers develop new malaria vaccine strategy based on ingestion of genetically modified starch

Researchers from two laboratories in northern France have successfully vaccinated and protected mice by feeding them starch derived from green algae and genetically modified to carry vaccine proteins.

21 Dec 2010

Cholera deaths in Haiti top 2,500, health ministry says

The Haitian health ministry on Sunday said there had been 2,535 cholera deaths since the outbreak hit in mid-October, "dashing hopes the fatality rate might be beginning to taper off," Agence France-Presse reports.

21 Dec 2010

Idera reports positive data from IMO-2125/ribavirin combination Phase 1 trial in null-responder HCV patients

Idera Pharmaceuticals, Inc. announced today preliminary data from a 4-week dose-ranging Phase 1 clinical trial of IMO-2125 in combination with ribavirin in 60 treatment-naïve patients with genotype 1 chronic hepatitis C virus (HCV) infection. In the trial, treatment with IMO-2125 in combination with ribavirin was well tolerated and achieved substantial decline in virus levels at two days after the first dose of IMO-2125 and after four weeks of treatment.

20 Dec 2010

Researchers recommend 'watchful waiting' over antibiotic treatment for many children with ear infections

As middle ear infections increase during the winter months, researchers from Ben-Gurion University of the Negev (BGU) suggest that in many cases the most appropriate treatment is "watchful waiting" instead of using antibiotics immediately.

20 Dec 2010

Research roundup: Gender differences in health spending; How the states could fare under the new law; Increased Medicare premiums

Health Affairs: Pronounced Gender And Age Differences Are Evident In Personal Health Care Spending Per Person - This paper examines health care spending by men and women in 2004, including comparisons "by age group, goods and services consumed, and payers, and an analysis of some of the most frequently cited health conditions and treatments associated with that spending."

20 Dec 2010

Walgreens partners with HHS to provide over $10M worth of flu shots for people without adequate health insurance

Walgreens and the U.S. Department of Health and Human Services (HHS) are teaming up in an effort to make 2011 a healthier New Year for those without adequate health insurance.

20 Dec 2010

Vaccine News and Research

Latest Vaccine News and Research

Financial Times examines how Brazil's state-run drug sector is engaging in partnerships at home, abroad

Silencing of specific genes of germinal cell lines reduces brain tumors

BROMG doctor calls for votes to win $25,000 Pepsi Refresh Grant to pay for more flu vaccine

Scientist discovers molecular switch controlling synthesis of ribosomes

Immunization with VLP vaccine results in functional, protective immune responses against RSV

Pfizer seeks FDA and EMA approval for expanded use of Prevnar 13 for pneumococcal disease

Medicago completes first part of H5N1 vaccine Phase II trial

Merck announces FDA approval for GARDASIL against HPV-related anal cancer

Combination of antigen and wax nanoparticles improves immunogenicity

FDA approves Gardasil for prevention of anal cancer

New online tool helps scientists to find gene promoters

AIDS patients with serum biomarkers are predisposed to immune reconstitution inflammatory syndrome

CoreMatrix delivers new cloud based, integrated, on demand marketing solutions

Biovest issues FAQ update on BiovaxID personalized cancer vaccine

Researchers develop new malaria vaccine strategy based on ingestion of genetically modified starch

Cholera deaths in Haiti top 2,500, health ministry says

Idera reports positive data from IMO-2125/ribavirin combination Phase 1 trial in null-responder HCV patients

Researchers recommend 'watchful waiting' over antibiotic treatment for many children with ear infections

Research roundup: Gender differences in health spending; How the states could fare under the new law; Increased Medicare premiums

Walgreens partners with HHS to provide over $10M worth of flu shots for people without adequate health insurance

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Vaccine News and Research

Latest Vaccine News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in